Please complete this short form to get in touch with a member of our team and we will get back to you as soon as we can.
It is essential that all NHS funding decisions are made in a robust, open and transparent way that ensures fair access to clinical treatments or interventions. This can be particularly challenging for treatments or interventions not routinely commissioned by the NHS, either locally by the Integrated Care Board or nationally by NHS England.
Developing and harmonising clinical policies, and incorporating rigorous processes, ensures consistent eligibility and treatment options across a local health and care system. This helps to address health inequalities, tackle the most urgent clinical priorities, and support delivery of the Triple Aim duty of better health for everyone, better care for all patients and sustainable NHS services.
We provide clinically evidence-based solutions that support population-based commissioning through our unrivalled expertise in individual funding requests, policy harmonisation, health economic modelling, clinical and cost-effective reviews, ethical decision making and corporate governance.
We identify system resource challenges which limit the introduction of new treatments and interventions for patients; agree common decision criteria to support the whole system to prioritise funding and make fair and equitable funding decisions between different clinical treatments and/ or interventions. We also ensure clinical policies are supported and implemented by all ICS stakeholder organisations.
Our support includes:
Our key strengths and expertise:
Find out more about our individual funding request service by accessing the resources below.
When three NHS England regional specialised commissioning teams needed additional capacity and capability to support them with their medicines optimisation responsibilities, dedicated resource from Arden & GEM’s clinical support service was provided.
Arden & GEM assigned a team to support Black Country ICB ensure there were harmonised clinical treatment policies in place across its new geographic footprint to ensure fair access to treatments and interventions.
Arden & GEM’s medicines optimisation team was engaged by NHS England East of England regional community pharmacy contracting team to review over 200 Dispensary Service Quality Scheme clinical audits by the end of the 2022/23 financial year.
A large trust in the Midlands commissioned Arden & GEM’s clinical support service to provide specialist pharmacist resource to deliver diabetes and hypertension clinics at one of their hospital sites to help manage complex patients.
Arden & GEM’s Pharmacy Lead will be joining the NHS Medicines Optimisation Conference on 30 November 2022 to share the aims of the Discharge Medicines Service and successful approaches to implementation.
In this article for PM Healthcare Journal, Arden & GEM's Medicines Optimisation team describe how their collaborative work with Black Country and West Birmingham ICS has uncovered the barriers to implementing a Discharge Medicines Service with positive impact for staff engagement and referrals.
Arden & GEM’s experienced clinical services team has undertaken 150 LeDeR reviews in a professional, timely and compassionate manner, producing actionable recommendations for service improvement.
In this blog for Healthcare Leader, Arden & GEM's Senior IFR Nurse, Charlotte Nuttley, considers the role that clinical policy development and harmonisation can play in helping ICSs to achieve the Triple Aim, deliver the COVID-19 recovery programme and make difficult funding decisions.
In this article for the Journal of Pharmacy Management, Arden & GEM's medicines optimisation team share their five-point approach to engaging with practices during the COVID-19 pandemic.
When a healthcare commissioning organisation in the East Midlands needed independent support to defend a contested decision in a High Court Judicial Review, Solutions for Public Health undertook a multifaceted review of the case which played a fundamental role in the ruling.
If you’d like to find out more about individual funding requests, prior approval and policy development please contact us here: